Pfizer jab shows 90.7% efficacy in trial in children
The Pfizer/BioNTech COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of children 5 to 11 years old, the U.S. drugmaker said on Friday.
Sixteen children in the ...
Stay up to date with the latest health news, wellness advice, medical research, and public health updates in Cyprus and around the world.